178 related articles for article (PubMed ID: 29549570)
1. Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside.
Buckley LF; Abbate A
BioDrugs; 2018 Apr; 32(2):111-118. PubMed ID: 29549570
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 blockade in cardiovascular diseases: a clinical update.
Buckley LF; Abbate A
Eur Heart J; 2018 Jun; 39(22):2063-2069. PubMed ID: 29584915
[TBL] [Abstract][Full Text] [Related]
3. Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.
Emmi G; Urban ML; Imazio M; Gattorno M; Maestroni S; Lopalco G; Cantarini L; Prisco D; Brucato A
Curr Cardiol Rep; 2018 Jun; 20(8):61. PubMed ID: 29904899
[TBL] [Abstract][Full Text] [Related]
4. Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.
Abbate A; Van Tassell BW; Biondi-Zoccai GG
BioDrugs; 2012 Aug; 26(4):217-33. PubMed ID: 22571369
[TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin-1 in heart failure and inflammatory heart disease.
Van Tassell BW; Raleigh JM; Abbate A
Curr Heart Fail Rep; 2015 Feb; 12(1):33-41. PubMed ID: 25315037
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.
Sugihara T; Okiyama N; Watanabe N; Miyasaka N; Kohsaka H
Arthritis Rheum; 2012 Aug; 64(8):2655-62. PubMed ID: 22392010
[TBL] [Abstract][Full Text] [Related]
7. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
Dinarello CA; Simon A; van der Meer JW
Nat Rev Drug Discov; 2012 Aug; 11(8):633-52. PubMed ID: 22850787
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 blockade treatment decreasing cardiovascular risk.
Zheng ZH; Zeng X; Nie XY; Cheng YJ; Liu J; Lin XX; Yao H; Ji CC; Chen XM; Jun F; Wu SH
Clin Cardiol; 2019 Oct; 42(10):942-951. PubMed ID: 31415103
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications.
Heydari FS; Zare S; Roohbakhsh A
Curr Rev Clin Exp Pharmacol; 2021; 16(3):219-227. PubMed ID: 32674739
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 as a therapeutic target in gout.
Dumusc A; So A
Curr Opin Rheumatol; 2015 Mar; 27(2):156-63. PubMed ID: 25633244
[TBL] [Abstract][Full Text] [Related]
11. Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
Burns JC; Koné-Paut I; Kuijpers T; Shimizu C; Tremoulet A; Arditi M
Arthritis Rheumatol; 2017 Feb; 69(2):268-276. PubMed ID: 27792871
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
Panahi M; Papanikolaou A; Torabi A; Zhang JG; Khan H; Vazir A; Hasham MG; Cleland JGF; Rosenthal NA; Harding SE; Sattler S
Cardiovasc Res; 2018 Sep; 114(11):1445-1461. PubMed ID: 30010800
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
Martinez FA
Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
[TBL] [Abstract][Full Text] [Related]
15. The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.
Smith JA
Curr Rheumatol Rep; 2016 Jun; 18(6):33. PubMed ID: 27105640
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope.
Qian N; Gao Y; Wang J; Wang Y
J Cell Mol Med; 2021 Jun; 25(12):5351-5357. PubMed ID: 33943014
[TBL] [Abstract][Full Text] [Related]
17. Limiting adverse cardiac remodeling after acute myocardial infarction by blocking interleukin-1.
Guntheroth WG
Am J Cardiol; 2010 Aug; 106(4):602. PubMed ID: 20691327
[No Abstract] [Full Text] [Related]
18. Cytokine and anti-cytokine strategies in inflammatory reaction modulation.
Delannoy I; Lekeux P; Miossec P
Vet Res; 1993; 24(6):449-67. PubMed ID: 8111428
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1β: a proinflammatory target for preventing atherosclerotic heart disease.
McCarty S; Frishman W
Cardiol Rev; 2014; 22(4):176-81. PubMed ID: 24618930
[TBL] [Abstract][Full Text] [Related]
20. IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications.
Apostolakis S; Vogiatzi K; Krambovitis E; Spandidos DA
Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):150-8. PubMed ID: 18473780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
